Intensity Therapeutics Inc.

INTS | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.02

-$0.09 (-2.19%)

At close: Sep 21, 2026, 4:00 PM ET

$4.01

-$0.01 (-0.25%)

Pre-market: Sep 22, 2026, 7:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $10.87M

Enterprise Value $1.43M

Beta 3.03

Average Volume 38.88K

Shares Outstanding (Diluted) 27.07M

Shares Change YoY 3486.22%

Institutional Ownership 0.71%

Exchange NASDAQ

ISIN US45828J2024

Price Performance

Price Change 1M -12.2%

Price Change 3M 0.5%

Price Change 6M -37.0%

Price Change YTD -60.5%

Price Change 1Y -38.1%

Price Change 3Y -95.6%

Price Change 5Y -97.3%

1M CAGR (ann.) -3.4%

1Y CAGR (ann.) -33.0%

5Y CAGR (ann.) N/A

All-Time CAGR -67.3%

Valuation

PE Ratio -0.83

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.02

PS Ratio N/A

Forward PS 31.00

PB Ratio 1.18

P/FCF Ratio -1.21

P/Adj. FCF Ratio -1.07

P/OCF Ratio -12.18

EV/Sales N/A

EV/EBIT -0.13

EV/EBITDA -0.17

EV/FCF -0.16

Earnings Yield -120.2%

FCF Yield -82.4%

Adj. FCF Yield -93.7%

Financial Health

Net Cash $9.43M

Total Debt $95K

Cash & Short-Term Investments $9.53M

Total Assets $11.52M

Current Ratio 5.00

Quick Ratio 5.00

Debt / Equity Ratio 0.01

Debt / EBITDA -0.01

Debt / FCF -0.01

OCF / Debt -94.25

Interest Coverage 0.00

Altman Z-Score -9.64

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -13.7%

Returns

Return on Assets -96.9%

Return on Equity -116.6%

Return on Invested Capital -123.3%

Return on Capital Employed -123.8%

Return on Tangible Assets -96.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 64.4%

EPS CAGR 5Y 45.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 24.6%

FCF CAGR 5Y -11.8%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y 55.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.94

EPS Growth Est (next Q) -37.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11

Price Target Upside 173.6%

Cash Flow

Operating Cash Flow $-8.95M

Free Cash Flow $-8.95M

Adj. Free Cash Flow $-10.18M

FCF Per Share -$0.33

OCF Per Share -$0.33

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-7K

Operating Income $-11.48M

EBITDA $-8.5M

Net Income $-11.16M

EPS (Diluted) -$4.83

Revenue / Employee N/A

Profit / Employee $-697.69K

Employees 16